Bristol-Myers Squibb sponsored the clinical studies and provided the study drugs in both the NivoMes and INITIATE clinical trials. The analyses of peripheral blood mononuclear cells (PBMCs) by flow cytometry, described in this manuscript, were not sponsored by any external funding.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.